A new device has been developed to detect malignant tumors

A gamma-locator, a device for searching and localizing malignant neoplasms, has been developed and prepared for certification at MEPhI.

The device allows to quickly and accurately detect the place of accumulation of the radiopharmaceutical injected into the patient's body before the operation on tumor removal - the signal lymph node, the university press service told "MV".

This helps the surgeon to localize residual tumor tissue and radically reduce the risk of damage to healthy tissue.

"Our device has a long history: nine years ago a pre-production sample appeared, which was distributed to several clinics for testing. Since then, the device has been finalized several times, and now it is fully prepared for certification," said Philipp Dubinin, head of the device development team.

The device has aroused the interest of specialists, as it replaces imported analogs, the use of which in Russia has recently been extremely difficult. The project team hopes that the device will appear on the market of medical devices as soon as it is certified.

The project team plans to obtain a registration certificate this year. In 2025 it is planned to produce a pre-serial batch of the device, in 2026 - a serial batch, and a full-fledged market launch in 2027.